FY26 HCD-W Coagulation Analyzer CPRR Consolidation Effort
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Jun 8, 2026 |
| Due Date: | |
| Solicitation No: | HT941026Q2004 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Award Date: Aug 30, 2026
- Contract Award Number: HT941026Q2004
- Task/Delivery Order Number:
- Contractor Awarded Unique Entity ID:
- Contract Opportunity Type: Consolidate/(Substantially) Bundle (Updated)
- Updated Published Date: Jun 08, 2026 06:12 pm EDT
- Original Published Date: May 11, 2026 09:58 am EDT
-
Requirements Strategy:
-
FAR 7.107-2 - Intent to consolidate requirements
Determination that consolidation is necessary and justified with the publication of the solicitation in Description.
-
FAR 7.107-2 - Intent to consolidate requirements
- Inactive Policy: 30 days after published date
- Updated Inactive Date: Jul 08, 2026
- Original Inactive Date: Jun 10, 2026
-
Initiative:
- None
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
The requirement is for a Cost Per Reportable Result (CPRR) contract for Coagulation analyzers to support the military treatment facilities (MTFs) and their workloads across HCD-W. The analyzers shall be provided under a cost-per-reportable-result (CPRR) agreement that includes all reagents, controls, supplies, consumables, coagulation analyzer equipment, parts, peripherals, and accessories, as well as all services necessary for coagulation analysis/testing, preventive maintenance, and repairs.
The analyzers will be utilized for performing coagulation testing. The CPRR price shall include:
- One (1) base year and four (4) option years.
- All reagents, standards, quality controls, supplies, consumable/disposable items, parts, accessories and any other item required for the proper operation of the Contractor’s equipment and necessary for the generation of a reportable result. This per reportable result price shall also encompass all costs associated with dilution; repeat and confirmatory testing required producing a single patient reportable result. It shall also include the material to perform as well as all other costs associated with quality control (QC), calibration and correlation study testing that is prescribed by the Clinical Laboratory Standards Institute (CLSI);
- All necessary maintenance to keep the equipment in good operating condition. This element includes both preventive maintenance and repairs;
- Training for Government personnel to include user-level training of core staff (up to 10 users on day and evening time frame), super-user level advanced training sessions (2 upon installation and 1 per instrument installed, per contract option year thereafter). Travel and lodging will be at the
- expense of the Contractor for super-user training conducted at Contractor training location;
- Delivery, installation and removal of laboratory analyzers; and
- Peripheral equipment such as printers, Uninterrupted Power Supply (UPS) units (minimum of 1-hour capability), and all parts required to operate in accordance with proposed capabilities.
- 2739T ROOSEVELT DRIVE OFFICE 143, BUILDING H-201T
- CAMP PENDLETON , CA 92055
- USA
- Bobbie Dobberstein
- bobbie.s.dobberstein.ctr@health.mil
- Phone Number 4789194484
- CHA-ON Gordon
- cha-on.p.gordon2.civ@health.mil
- Phone Number 7262030109
- Jun 08, 2026 06:12 pm EDTConsolidate/(Substantially) Bundle (Updated)
- Jun 08, 2026 06:04 pm EDT Consolidate/(Substantially) Bundle (Updated)
- May 11, 2026 09:58 am EDT Consolidate/(Substantially) Bundle (Original)
Related Document
See Also
Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/17/2026
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 9/18/2026
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 10/02/2026